SLU-PP-332

SLU-PP-332 (C18H14N2O2, CAS: 303760-60-3) acts as a potent pan-ERR agonist for metabolic research applications. It supports exercise mimetic studies by promoting mitochondrial function and fatty acid oxidation. Choose Powerock Pharma for purity and results.

Chemical name: SLU-PP-332 (C18H14N2O2)
Product quantity: 60 capsules, 300 mcg per capsule
Total amount of substance: 18 mg

Physical form: Powder encapsulated in a Capsules

CAS Number: 303760-60-3

Molecular weight: 290.32 g/mol
Chemical formula: C18H14N2O2
Physical form: White crystalline powder, soluble in DMSO
Purity: ≥98% (HPLC tested)
Format: Laboratory-grade powder for analytical use only (not for human consumption)
Storage conditions: Store at -20°C, protected from light and moisture

Physical form: Powder encapsulated in a Capsules

Category: SARMs

Product intended for research purposes

Properties SLU-PP-332:

SLU-PP-332 is recognized as a potent pan-estrogen related receptor (ERR) agonist, making it a preferred choice for researchers studying metabolic enhancement, exercise mimetics, and mitochondrial function. This laboratory-grade compound is a synthetic molecule designed to activate ERRα, ERRβ, and ERRγ receptors with varying potency (EC50 values of 98 nM, 230 nM, and 430 nM respectively). By mimicking the beneficial effects of physical exercise at the molecular level—SLU-PP-332 supports improvements in energy expenditure, fatty acid oxidation, and cellular respiration. Its selective activation of metabolic pathways makes it an invaluable tool for investigating obesity, metabolic syndrome, and age-related physiological decline.

Mechanism of action:

SLU-PP-332 acts by binding to and activating the estrogen-related receptor (ERR) pathway, specifically targeting ERRα, ERRβ, and ERRγ. This selective activation promotes robust mitochondrial biogenesis and enhances oxidative skeletal muscle fiber formation, which is crucial for metabolic regulation and endurance capacity. Unlike many metabolic modulators, SLU-PP-332 functions as an exercise mimetic without affecting appetite or food intake. Its targeted mechanism ensures activation of genetic programs typically induced by physical exercise, including enhanced cellular respiration and increased fatty acid oxidation, while maintaining minimal off-target effects. The compound’s approximately 4-5 fold selectivity for ERRα over ERRγ provides focused metabolic activation, making it an ideal candidate for research into metabolic diseases and age-related decline.

Benefits:

Consistent research use of SLU-PP-332 demonstrates enhanced endurance capacity, increased energy expenditure, and improved mitochondrial function. Secondary benefits observed in studies include significant reduction in fat accumulation (obese models gained 10x less fat and lost 12% of body weight), improved metabolic health markers, and protection against age-related muscle atrophy. SLU-PP-332 is particularly effective for research targeting metabolic syndrome, obesity, type 2 diabetes, and counteracting physiological decline associated with aging. Preclinical data shows enhanced type IIa oxidative skeletal muscle fibers and improved aerobic exercise genetic program activation.

Why Powerock Pharma:

At Powerock Pharma, we are dedicated to excellence. Every batch of SLU-PP-332 is manufactured in GMP, HACCP, and ISO 13485 certified facilities. Our advanced HPLC testing guarantees ≥98% purity, ensuring you receive a product that is both safe and reliable. We collaborate with leading laboratories to validate potency and consistency, so you can trust Powerock Pharma for your most critical research needs.

Summary:

If you’re seeking to advance your research in metabolic enhancement or exercise mimetics, SLU-PP-332 is the solution. Backed by Powerock Pharma’s rigorous quality controls, this compound provides the reliability and efficacy your studies demand. Don’t compromise on quality—order SLU-PP-332 today and elevate your research outcomes.

How to use SLU-PP-332

Research protocol:

Administer SLU-PP-332 according to your research protocol. The compound can be delivered via intraperitoneal injection or prepared in appropriate vehicle solutions (typically 3% DMSO), depending on the specific requirements of your study.

Administration schedule:

For consistency and reliable data, administer SLU-PP-332 at the same time(s) each day throughout the research period.

Cycle length:

A typical research cycle lasts 2–8 weeks, allowing sufficient time to observe and document the compound’s effects on metabolic function, mitochondrial activity, and exercise capacity.

Recommended dosage for Model A (smaller subjects):

For smaller research models, a starting dosage of 25 mg/kg per administration is commonly used. Adjust as necessary based on research findings and objectives.

Recommended dosage for Model B (larger subjects):

For larger research models, a starting dosage of 50 mg/kg per administration (often divided into twice-daily doses) is recommended. Adjust as needed according to study design and outcomes.

Monitoring:

Continuous monitoring of all research subjects is essential. Record metabolic, physiological, and behavioral responses, including body weight, energy expenditure, and endurance capacity. Address any adverse events promptly to ensure accurate and ethical data collection.

How to Stack SLU-PP-332

Stack #1: SLU-PP-332 + Cardarine (GW501516)

For synergistic metabolic enhancement and fat oxidation. This combination activates complementary pathways (PPARδ and ERR), resulting in improved endurance and accelerated fat loss.

Stack #2: SLU-PP-332 + AICAR

For amplified exercise mimetic effects. AICAR activates AMPK pathways while SLU-PP-332 targets ERR receptors, creating a comprehensive metabolic activation strategy.

Stack #3: SLU-PP-332 + NMN (Nicotinamide Mononucleotide)

For mitochondrial health and cellular energy. This stack promotes NAD+ availability alongside ERR activation, supporting enhanced cellular metabolism and healthy aging.

Stack #4: SLU-PP-332 + Mots-c

For metabolic regulation and insulin sensitivity. Mots-c is a mitochondrial-derived peptide that complements SLU-PP-332’s effects on metabolic function and glucose homeostasis.

Stack #5: SLU-PP-332 + NAD+ precursors

For comprehensive cellular energy optimization. NAD+ boosters work synergistically with SLU-PP-332 to maximize mitochondrial function and support metabolic research objectives.

Frequently Asked Questions About SLU-PP-332

What is the recommended dosage for research purposes?+

Typical research dosages are 25-50 mg/kg per administration, depending on model size and study design, with twice-daily administration commonly employed in preclinical studies.

Can this product be used in combination with other compounds?+

Yes, SLU-PP-332 is frequently studied in combination with other exercise mimetics and metabolic modulators for synergistic effects. Always ensure compatibility within your research protocol.

What are the potential side effects observed in research?+

Animal studies report favorable safety profiles, though as with any novel compound, subjects should be closely monitored for unexpected physiological responses.

Is this product safe for long-term research?+

Current preclinical data suggest good tolerability for extended research cycles up to 8 weeks, though all long-term effects should be carefully documented and reviewed.

How should this product be stored?+

Store SLU-PP-332 at -20°C, protected from light and moisture to maintain stability and potency. When properly stored, the compound remains stable for at least 2 years.

What makes Powerock Pharma products reliable for research?+

Powerock Pharma products are manufactured in certified facilities, undergo rigorous HPLC purity and potency testing, and are trusted by researchers worldwide for their consistency and reliability.